Alumis is  a precision medicines company looking to eliminate the “all comer” approach that is seen with today’s treatments for people with autoimmune disease. They are leveraging a precision analytics platform, powered by Foresite Labs, coupled with a team of experts with deep experience in precision medicine drug development and immunology, in order to create medicines that change the lives of people with autoimmune disease.

Biotechnology

Education

Alumis

Martin Babler

Grace Halteh

Roman Rubio

Karen Pellett

Lily Gong

Lance Shinseki

John Schroer

Ruixiao Lu

Tim Owens

Jörn Drappa

Joshua Hoffman

David Zhang

Roy Hardiman

Derrick Richardson

David Goldstein

Mark Bradley

Sara Klein

Clinical Development and Research

Leadership Team

Clinical Development Team

Development and Information Systems

Medical and Regulatory Affairs

Teams at Alumis

Clinical Development and Research

Leadership Team

Clinical Development Team

Development and Information Systems

Medical and Regulatory Affairs